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The growth of an individual is deeply inﬂuenced by the regulation of cell growth and division, both of which also
contribute to a wide variety of pathological conditions, including cancer, diabetes, and inﬂammation. To identify
a major regulator of human growth, we performed positional cloning in an autosomal recessive type of profound
short stature, anauxetic dysplasia. Homozygosity mapping led to the identiﬁcation of novel mutations in the RMRP
gene, which was previously known to cause two milder types of short stature with susceptibility to cancer, cartilage
hair hypoplasia, and metaphyseal dysplasia without hypotrichosis. We show that different RMRP gene mutations
lead to decreased cell growth by impairing ribosomal assembly and by altering cyclin-dependent cell cycle regulation.
Clinical heterogeneity is explained by a correlation between the level and type of functional impairment in vitro
and the severity of short stature or predisposition to cancer. Whereas the cartilage hair hypoplasia founder mutation
affects both pathways intermediately, anauxetic dysplasia mutations do not affect B-cyclin messenger RNA (mRNA)
levels but do severely incapacitate ribosomal assembly via defective endonucleolytic cleavage. Anauxetic dysplasia
mutations thus lead to poor processing of ribosomal RNA while allowing normal mRNA processing and, therefore,
genetically separate the different functions of RNase MRP.
Introduction
The growth of an individual is maintained by many fac-
tors and depends, for the most part, on the size and
number of cells the individual contains. Both parameters
are deeply inﬂuenced by the regulation of cell growth
and division. Dysfunction of the signaling pathways that
control cell growth results in cells of altered size or num-
ber and can lead to developmental errors and contribute
to a wide variety of pathological conditions, including
cancer, diabetes, and inﬂammation (Hall et al. 2004).
Research on common types of human growth deﬁ-
ciencies in recent years has led to the elucidation of
genetic etiologies for isolated growth hormone deﬁcien-
cies, combined pituitary hormone deﬁciencies (Rosen-
feld and Hwa 2004), and a variety of skeletal dysplasias
revealing molecular pathways, including defects in ex-
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tracellular structural proteins, macromolecules, meta-
bolic pathways, signal transduction mechanisms, nu-
clear proteins, oncogenes, and RNA and DNA pro-
cessing (Superti-Furga et al. 2001). To identify a major
contributor to cell growth regulation, we performed po-
sitional cloning in a rare autosomal recessive type of
extreme short stature, named “anauxetic” dysplasia af-
ter the Greek term for “to not let grow” (Horn et al.
2001). Anauxetic dysplasia (MIM 607095) is an au-
tosomal recessive spondylometaepiphyseal dysplasia
characterized by the prenatal onset of extreme short
stature, an adult height of !85 cm, hypodontia, and
mild mental retardation (Horn et al. 2001) (ﬁg. 1). Ma-
jor radiographic characteristics are late-maturating,
ovoid vertebral bodies with concave dorsal surfaces in
the lumbar region; small capital femoral epiphyses; hy-
poplastic femoral necks; hypoplastic iliac bodies and
shallow acetabulae; irregular metaphyseal mineraliza-
tion and demarcation of the long tubular bones; short
metacarpals with widened shafts (I and V); very short
and broad phalanges with small, late-ossifying epiph-
yses and bullet-shaped middle phalanges; and midfacial
hypoplasia. The number of chondrocytes is severely re-
duced in the resting and proliferating cartilage, with
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Figure 1 Clinical and x-ray characteristics of anauxetic dysplasia. A, far left and near left, Patient, aged 16.5, from family 2 (Horn et
al. 2001), showing severe short stature with hyperlordosis (height of 74 cm). Upper right, X-ray of the left arm at age 7, showing extremely
retarded carpal ossiﬁcation corresponding to ∼3 mo bone age, as well as short and broad tubular bones. Lower right, X-ray of spine and pelvis
at age 7, showing decreased vertical dimension of the ilia, unossiﬁed femoral necks, and small, irregular capital femoral epiphyses. B, X-rays
of lower extremities at age 7 mo (top) and pelvis at age 2 (bottom) of patient 3, showing d-shaped metaphyses with irregular borders and pelvic
changes similar to those in panel A.
diminished columnization of the hypertrophic zone.
We report here the identiﬁcation of RMRP gene mu-
tations as the underlying genetic defect of anauxetic
dysplasia, which, therefore, is allelic to cartilage hair
hypoplasia (CHH [MIM 250250]) (Ridanpaa et al.
2001), as well as metaphyseal dysplasia without hy-
potrichosis (MDWH [MIM 250460]) (Bonafe et al.
2002; Ridanpaa et al. 2003b). The RMRP gene encodes
the untranslated RNA subunit of the ribonucleoprotein
endoribonuclease, RNase MRP. The disease-causing
functional impairment of the RMRP gene product in
CHH mutations in humans is unknown (Ridanpaa et
al. 2003a). The RMRP ortholog in yeast, nme1, is in-
volved in ribosome synthesis, the generation of RNA
primers for mitochondrial DNA replication (Welting et
al. 2004), and the degradation of cell cycle–regulated
mRNA (Gill et al. 2004). We performed functional stud-
ies in yeast and humans to provide the ﬁrst physiological
demonstration of a function for RNase MRP in mam-
malian cells. Furthermore, we explain clinical hetero-
geneity by a correlation between the level and type of
functional impairment in vitro and the severity of short
stature or the presence of cancer predisposition.
Material and Methods
Patients
This study was approved by the ethical review board
of the Friedrich-Alexander University in Erlangen-Nu¨rn-
berg, Germany. After receiving informed consent, we
obtained peripheral blood samples frommembers of two
previously published families (Menger et al. 1996; Horn
et al. 2001) and from one new sporadic patient with
spondylometaepiphyseal dysplasia Menger type, or an-
auxetic dysplasia. From the Jordanian family 1 (Menger
et al. 1996), three affected children, six unaffected chil-
dren, and their consanguineous parents were available.
From the German family 2 (Horn et al. 2001), two af-
fected children (one living and one deceased) and their
nonconsanguineous parents were recruited. From the liv-
ing child of family 2, a ﬁbroblast culture from a skin
biopsy and RNA samples from peripheral blood col-
lected in PAXgene tubes (PreAnalytiX) were also ob-
tained. The PAXgene tube contains a proprietary reagent
that immediately stabilizes intracellular RNA for days
at room temperature and for weeks at 4C. Speciﬁc con-
sent was obtained from the respective parents to publish
photographs of their children. The living patient from
family 2 (Horn et al. 2001), who showed severe short
stature with hyperlordosis (height of 74 cm, weight of
11.8 kg, and head circumference of 50.2 cm) was re-
evaluated at age 16.5 (ﬁg. 1A). Because of atlantoaxial
subluxation, he underwent cervical fusion. Puberty was
somewhat delayed but was otherwise normal. The pa-
tient is mildly mentally retarded (capable of some read-
ing, writing, and calculating up to the number 20).
The sporadic case, patient 3, of German origin, (ﬁg.
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1B) was the deceased offspring of nonconsanguineous,
healthy parents, who have two additional healthy chil-
dren. Extreme short stature was evident at term birth,
when body length was 37 cm, head circumference was
31 cm, and weight was 2.02 kg. As in the deceased
patient from family 2, there was spasticity caused by
cervical cord compression. This child also showed men-
tal retardation and severe growth failure, with a body
length of only 53 cm at age 7. Radiographic signs in-
cluded extremely slow epiphyseal maturation, meta-
physeal irregularities, hypoplastic femoral necks, thick
and short tubular bones of the hands, and ovoid ver-
tebral bodies. Recurrent pneumonias due to a progres-
sive thoracic deformity ﬁnally led to lethal respiratory
insufﬁciency.
Linkage Analysis
Genomic DNA was extracted from peripheral blood
lymphocytes by standard salt precipitationmethods and,
from the deceased patient of family 2, with the use of
a dried blood spot. Homozygosity mapping was per-
formed with a genomewide set of 385 evenly distributed
microsatellite markers, with an average distance of 11
cM, on the basis of the Ge´ne´thon ﬁnal linkage map (Dib
et al. 1996) and as described elsewhere (Horn et al.
2000). Markers were labeled with ﬂuorescent dyes and
ampliﬁed by PCR. PCRs were pooled for genotyping on
a Prism 377 Genetic Analyzer (Applied Biosystems) run-
ning Genescan (v. 2.1) and Genotyper (v. 2.0) software
(Applied Biosystems).
We used the MLINK program of the LINKAGE soft-
ware package and the LINKRUN software to calculate
two-point LOD scores between the disease phenotype
and each of the markers, assuming a recessive mode of
inheritance with full penetrance (Lathrop and Lalouel
1984), and we used Genehunter (v. 1) for multipoint
linkage analysis. A set of additional markers (D9S1679,
D9S1833, D9S126, D9S1114, D9S161, D9S263,
D9S746, D9S1678, D9S270, D9S1875, D9S2025,
D9S1868, D9S52, D9S251, D9S43, D9S1845,
D9S78, D9S1817, D9S1804, D9S1791, D9S1879,
and D9S175) for ﬁne-mapping analysis was geno-
typed in families 1 and 2 on an ABI 3100 capillary
sequencer. We manually reconstructed haplotypes for
the region ﬂanked by the markers D9S1679 and
D9S1874, with marker order based on the draft human
genomic sequence (National Center for Biotechnology
Information).
Mutation Analysis
Exons of positional candidate genes were ampliﬁed
by PCR with the use of intronic and additional exonic
primers for larger exons. Concerning the RMRP gene,
we ampliﬁed the coding region, the promoter region,
and the TATA box in all members of family 1 and 2
and in patient 3. The PCR products were puriﬁed with
Filter plates LSKMPCR50 (Millipore) on a Tecan liquid
handling system, and sequencing reactions were per-
formed on both strands with the use of the BigDye
Terminator Cycle Sequencing Kit (v. 3.1 [Applied Bio-
systems]), in accordance with the manufacturer’s
instructions. After puriﬁcation with ﬁlter plates
LSKS09624 (Millipore), the products were analyzed on
an ABI Genetic Analyzer 3730 (Applied Biosystems)
with SeqMan II software (DNASTAR).
The nucleotide sequence of the human RMRP gene
was aligned with the sequences of orthologs from other
species with use of the ClustalW Multiple Sequence
Alignment algorithm (Baylor College of Medicine) and
AlignX of the Vector NTI Suite 6.0 (InforMax). RNA
was isolated from the ﬁbroblasts and lymphocytes of
one patient and the parents of family 2, as well as from
10 controls with normal growth development, with use
of the RNeasyMini Kit (Qiagen). The synthesis of cDNA
was performed with the use of a Superscript II Reverse
Transcriptase Kit with random hexamer primers (Invi-
trogen), in a total volume of 20 ml.
Analysis of Mutant RMRP Constructs and Real-Time
PCR Assays
By PCR, we ampliﬁed wild-type and mutant RMRP,
using lymphocyte DNA from a healthy control and from
affected patients as template, and we subcloned the
RMRP into pcDNA3.1 with the Directional TOPO Ex-
pression Kit vector (Invitrogen). To generate the cartilage
hair hypoplasia founder mutation 70ArG, we mod-
iﬁed the wild-type RMRP construct, using the Quik-
Change site-directed mutagenesis kit (Stratagene), in ac-
cordance with the manufacturer’s instructions.
We transiently transfected ﬁbroblast cells from a
healthy donor, with 500 ng of each RMRP construct
(wild-type, 14GrA, 90_91AGrGC, ins111_112A-
CGTAGACATTCCT,254CrG, and70ArG), using
Lipofectamine 2000 and Plus Reagent (Invitrogen). We
also transfected dermal ﬁbroblasts from the affected, liv-
ing child of family 2, with 500 ng of the RMRP wild-
type construct. As a negative control, the empty vector
was also transfected. We collected cells at 12 h, 36 h,
48 h, and 60 h after transfection and extracted RNA
and DNA, using TRIzol Reagent (Invitrogen). RMRP,
CCNA2, CCNB2, 5.8S ribosomal RNA (rRNA), and
ITS-1–bound 5.8S rRNA expression was quantiﬁed by
real-time PCR (ﬁg. 2). TaqMan primers and probes were
newly designed with the Primer Express Software v2.0
(Applied Biosystems) for RMRP (GenBank accession
number M29916), human ribosomal DNA complete
repeating unit (GenBank accession number U13369),
CCNB2 (GenBank accession number AY864066), and
CCNA2 (GenBank accession number NM_001237). We
used minor-grove-binder probes containing a ﬂuorop-
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Figure 2 Scheme of rRNA processing in yeast and humans. The
legend is available in its entirety in the online edition of The American
Journal of Human Genetics.
Figure 3 Summary of the genome scan for anauxetic dysplasia
or spondylometaphyseal dysplasia (SMED) with use of GENE-
HUNTER-PLUS (Kong and Cox 1997). The legend is available in its
entirety in the online edition of The American Journal of Human
Genetics.
hore 5′ FAM modiﬁcation as reporter and a 3′ nonﬂu-
orescent quencher. The multiplex assay for each sample
was performed in 384-well optical plates (Applied Bio-
systems) with a ﬁnal volume of 20 ml each. All mea-
surements, each from three different cultures, were per-
formed in quadruplicate. Quantitative RT-PCR was
performed with the QuantiTect Probe RT-PCR Kit (Qia-
gen) with an ABI Taqman 7900HT. After the evaluation
of normalization to three different endogenous controls
(18s-RNA, b-2-microglobulin, and RNA-II-polymer-
ase), we performed experiments with RNA-II-polymer-
ase (RPII) as the internal standard. We veriﬁed the rel-
ative cell count by targeting albumin genomic DNA,
normalizing it to the level at 12 h after transfection (Thiel
et al. 2003).
Analysis of Mutant nme1 Constructs in Saccharomyces
cerevisiae
Plasmid DNA pMES140 carrying the full-length nme1
gene was used as a template (Schmitt 1999).Wemodiﬁed
the wild-type nme1 construct, using the QuikChange
site-directed mutagenesis kit (Stratagene) to generate the
28TrC (M1, corresponding to human 14GrA by
sequence alignment), 279CrG (M2, corresponding to
human 254CrG by sequence alignment), 18TrC
(M3, corresponding to human 14GrA by structural
homology), and 319TrG (M4, corresponding to hu-
man 254CrG by structural homology) variants. Mu-
tant variants were exchanged for the wild type with use
of a standard plasmid shuttle (Shadel et al. 2000). Yeast
was grown on YPD medium (1% yeast extract, 2% pep-
tone, and 2% dextrose), RNA was extracted, and 5.8S
rRNA was examined directly as described elsewhere
(Shadel et al. 2000).
Mutant yeast strains were analyzed for temperature-
conditional growth on YPD or YPG (1% yeast, 2% pep-
tone, and 3% glycerol) plates and were compared with
congenic wild-type strain (Shadel et al. 2000).Metabolic
activity was indicated by adenine consumption (Shadel
et al. 2000) and the resulting development of a red color.
Mitomycin C Resistance Analysis
Skin ﬁbroblasts from the living patient of family 2
were cultured on microscopic slides in Quadriperm
dishes in DMEM/Ham’s F12 medium containing 20%
fetal calf serum and supplemented with Ultraser (4%).
The cultures were kept at 37C in a 5%CO2 atmosphere.
Mitomycin C was added in various ﬁnal concentrations
(0.025 mg/ml, 0.05 mg/ml, 0.1mg/ml, and 0.2 mg/ml) 24
h before harvesting. One slide was cultured without
mitomycin C. As a control, an identical experiment
was performed in parallel on ﬁbroblast cultures derived
from the skin of a healthy individual. Chromosomal
breakage was analyzed on Giemsa-stained metaphase
preparations.
Results
Positional Cloning
Genomewide homozygosity mapping in the large,
consanguineous family 1 with both parents, three af-
fected children, and ﬁve unaffected children revealed a
18.7-cM region on chromosome bands 9p13–9p21,with
a maximum multipoint LOD score of 3.012 between
markers D9S171 and D9S1874 (ﬁg. 3). Fine mapping
with additional markers and family members in families
1 and 2 reﬁned the linkage region to 17.1 cM between
markers D9S1114 and D9S1874, resulting in a 11.15-
Mb candidate interval, with a maximum LOD score of
3.158.
According to the National Center for Biotechnology
Information Map Viewer and the UCSC Genome
Browser, the critical interval contained 77 known genes.
Only when using GeneSeeker (van Driel et al. 2003) did
we identify the RMRP gene to also be located in the
interval. Sequencing ofRMRP in the anauxetic dysplasia
families revealed a homozygous insertion mutation,
ins111_112ACGTAGACATTCCT, in the three affected
patients from family 1 and revealed compound hetero-
zygous mutations in both affected members of fam-
ily 2 (14GrA and 90_91AGrGC), as well as in pa-
tient 3 (90_91AGrGC and 254CrG) (ﬁg. 4A–4E).
All four novel mutations affect evolutionarily high-
ly conserved regions and were absent in 378 control
chromosomes.
The 90_91AGrGC mutation occurred in family 2
and in patient 3, both of whom originated from the
same German region. Accordingly, the mutation was
found to reside on a common ancestral haplotype in both
families, conﬁrming a founder effect (SNP haplotype:
56G, 48A, 6A, 156C, 177T, and 274C).
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Figure 4 RMRP gene mutations identiﬁed in anauxetic dysplasia
patients of families 1–3 and their evolutionary conservation in various
orthologs. Affected members of family 1 were homozygous for a 14-
bp insertion at position 111_112 (A), affected members of family 2
were compound heterozygous for the mutations 90_91AGrGC (B)
and 14GrA (C), and patient 3 was compound heterozygous for the
90_91AGrGC mutation (B) and for a 254CrG mutation (D). E,
Signiﬁcant decrease inRMRP expression of the14GrAmutant allele
(*), as revealed by RT-PCR in the patient of family 2.
Functional Studies in Yeast
In yeast, the anauxetic dysplasia point mutations re-
sulted only in mild growth retardation and reduced met-
abolic activity, whereas the 5.8SL/5.8SS ratio was unal-
tered and colony size was near normal on different
carbon sources and at different temperatures (ﬁg. 5C).
Human Functional Analyses
Concerning the14GrA mutation, sequencing of the
patients’ RT-PCR products, as well as allele-speciﬁc
RT-PCR, showed a lack of expression of this mutant
RMRP allele (ﬁg. 4E). Expression levels in the cells of
a patient from family 2 (carrying the 90_91AGrGC
and 14GrA mutations) showed a 1.8-fold increase in
uncleaved pre-5.8S rRNA bound to ITS-1 in ﬁbroblasts
and a 1.44-fold increase in lymphocytes, indicating de-
fective rRNA processing (ﬁg. 6A–6D). Transfection of
the patient’s very poorly growing ﬁbroblasts with the
wild-type RMRP construct signiﬁcantly increased the
growth rate and production of the 5.8S rRNA (ﬁg. 6E
and 6F).
Human ﬁbroblast cells transfected with the RMRP
wild type showed a 30-fold increase in cell count in 48
h, cells transfected with the anauxetic dysplasia muta-
tions showed only a minor increase in cell count, and
the CHH founder mutation showed an intermediate re-
duction (ﬁg. 7A). Accordingly, the wild-type transfected
cells showed a shift to a slightly higher proportion of
cleaved 5.8S rRNA, whereas all cells transfected with
mutant constructs demonstrated diminished endonu-
cleolytic cleavage at the ITS-1/5.8S rRNA junction site
(ﬁg. 7B). This effect was the most pronounced in the
anauxetic dysplasia mutations.
With respect to cyclin-dependent cell cycle function in
human RNase MRP, except for cells with the naturally
nonexpressed 14GrA mutation, all cells overexpress-
ing RMRP mutants showed signiﬁcantly decreased cy-
clin A2 levels correlating with the reduction in the
growth rate and the clinical phenotype (ﬁg. 7C and
7D). In contrast to the anauxetic dysplasia mutations,
the CHH founder mutation 70ArG had signiﬁcantly
increased cyclin B2 mRNA levels. Mitomycin C sensi-
tivity testing in ﬁbroblasts of the patient of family 2
revealed no evidence for chromosomal instability (data
not shown).
Discussion
Linkage analysis in two families mapped anauxetic
dysplasia to a 17.1-cM interval in 9p13–9p21. These
11.15 Mb spanning the region between D9S1114 and
D9S1874 contained 77 known genes without an out-
standing candidate. Since untranslated RNA genes are
not annotated in the commonly used databases, only
when using GeneSeeker (van Driel et al. 2003) did we
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Figure 6 A–D, Assessment of RMRP expression and endonucleolytic cleavage for ribosomal assembly in native cells of one patient from
family 2 (P) with anauxetic dysplasia and compound heterozygosity for the RMRP mutations 90_91AGrGC and 14GrA. E and F, Rescue
of phenotype by wild-type hyperexpression. A, Expression of RMRP was decreased 13-fold in the patient’s lymphocytes and threefold in his
ﬁbroblasts (B), compared with average levels in 11 healthy control individuals with (C) and without outliers (C′). Decreased endonucleolytic
cleavage in the patient, demonstrated by the increased ratio of 5.8S rRNA bound to ITS-1 versus cleaved 5.8S rRNA of 1.44-fold in lymphocytes
(C) and 1.8-fold in ﬁbroblasts (D). E, Rescue of phenotype by wild-type hyperexpression, as shown by the dramatically increasing cell count
up to 48 h after transfection (dark bars) in comparison to transfection with the empty vector (pale bars). F, Increase of cell count correlates
with increasing endonucleolytic cleavage in ribosomal assembly as measured by the ratio of 5.8S rRNA bound to ITS-1 versus cleaved 5.8S
rRNA.
identify theRMRP gene to also be located in the interval.
Mutations of the RMRP gene are known to cause car-
tilage hair hypoplasia (CHH [MIM 250250]) (Ridanpaa
et al. 2001), as well as metaphyseal dysplasia without
hypotrichosis (MDWH [MIM 250460]) (Bonafe et al.
2002; Ridanpaa et al. 2003b). Both are milder types of
autosomal recessive skeletal dysplasias (adult heights
ranging from 103.7 cm to 149.0 cm), with proliferative
bone marrow dysfunction and predisposition to malig-
nant tumors in patients with CHH (Makitie et al. 1995).
In contrast to those in patients with anauxetic dysplasia,
vertebral bodies in patients with CHH and MDWH are
only mildly affected, the pelvic appearance is normal,
and the epiphyses are not dysplastic.Mutational analysis
in the RMRP gene in our patients with anauxetic dys-
plasia subsequently revealed homozygous or compound
heterozygous mutations in every patient from the three
unrelated families (ﬁg. 4A–4E). All of these novel mu-
tations affect evolutionarily highly conserved regions
and were absent in healthy controls. One mutation
(90_91AGrGC), which occurred in two families orig-
inating from the same region, was shown to reside on
a common ancestral haplotype, conﬁrming a founder
effect.
The RMRP gene encodes the untranslated RNA sub-
unit of the ribonucleoprotein endoribonuclease, RNase
MRP. In yeast, it is involved in ribosome synthesis, the
generation of RNA primers for mitochondrial DNA rep-
lication (Welting et al. 2004), and the degradation of
cell cycle–regulated mRNA (Gill et al. 2004). The dis-
ease-causing functional impairment of the RMRP gene
product in CHH mutations in humans is unknown (Ri-
danpaa et al. 2003a). The founder mutation 70ArG
contributes to 92% of Finnish and 48% of non-Finnish
patients with CHH (Ridanpaa et al. 2002). When we
compared mutations found in the different RMRP gene
phenotypes with sites of known RNA protein or RNA-
RNA interaction (Welting et al. 2004), we were unable
to identify any obvious genotype-phenotype correlation.
Therefore, we assume that the clinical heterogeneity of
RMRPmutations might be explained by different effects
on the overall structure or activity of the enzyme.
In accordance with previous predictions of theRMRP
structure published elsewhere (Topper and Clayton
1990; Schmitt et al. 1993; Pluk et al. 1999), the pres-
ent model (ﬁg. 5A) suggests that the site of the
90_91AGrGC mutation is located in a loop. The size
of the loop and the pairing of the adjacent bases, how-
ever, show some degree of variation among the different
predictions. To obtain a more detailed picture of the
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Figure 7 Comparison of different RMRP mutants overexpressed in transiently transfected human wild-type ﬁbroblasts, with reference to
relative cell counts and endonucleolytic cleavage activity in ribosomal assembly and cyclin levels. A, Relative cell count normalized to the level
at 12 h after transfection in anauxetic dysplasia mutants and the CHH founder mutation 70ArG, as compared with the wild-type transfected
cells. B, Impaired growth correlating with decreased endonucleolytic cleavage activity investigated via the ratio of 5.8s rRNA bound to ITS-1
versus cleaved 5.8s rRNA normalized to 12 h after transfection. C, Decreased CCNA2 expression in naturally expressed anauxetic dysplasia
mutations and less severe in the CHH founder mutation. D, Signiﬁcantly increased CCNB2 expression in the 70ArG mutation. Note that
the 14GrA mutation is not expressed in vivo.
geometry of the respective region, we compared the se-
quence properties of the loop to RNA for which a three-
dimensional structure is available.
Nucleotides 91–94 match the consensus sequence of
a GNRA tetraloop, a motif that adopts a well-deﬁned
three-dimensional structure (Heus and Pardi 1991) and
that has been shown previously to be involved in RNA-
protein interaction, for example, in the complex of the
nutRboxB RNA with the N-protein (Scha¨rpf et al.
2000). In the latter structure, the ﬁrst and last nucleo-
tide of the GNRA tetraloop form a noncanonical
(“sheared”) base pair (ﬁg. 8). Mutation of 91GrC
destroys this base pair and, thus, may severely alter the
structure of this loop and its ability to interact with
proteins.
The 254CrG mutation is located at the end of a
large loop containing the LRI-I sequence. The exchange
of 254CrG might promote base pairing in the re-
spective region between U252-U253-G254 and the
complementary stretch A237-A236-C235, which is lo-
cated at the other end of this loop (ﬁg. 5A). This en-
hanced base pairing might result in a distortion of the
LRI-I sequence and, thus, hamper its interaction with
the LRI-I sequence located around nucleotide 74. The
LRI-1 forms the central core of domain 1, which also
includes helixes I–V and is responsible for cleavage ac-
tivity (Schmitt 1999). Therefore, disruption of LRI-I
may severely hamper the cleavage activity of RNase
MRP.
The insertion after position 111 is located within
helix VII, belonging to the second domain of RNase
MRP RNA (ﬁg. 5A), which is thought to provide en-
zyme-speciﬁc functions such as substrate speciﬁcity
(Schmitt 1999). Its location within a loop might explain
why such a large insertion of 14 nucleotides does not
result in a complete disruption of the RMRP structure,
which should be lethal.
Lack of expression of the 14GrA mutation may
indicate a yet-unknown regulatory or intragenic pro-
moter region in the evolutionarily conserved region
3 to 31. However, this ﬁnding is unexpected, since
RNA polymerase III promoters containing a TATA box
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Figure 8 Structural properties of a GNRA tetraloop and impli-
cations for RNA-protein interaction, as evident from the nutboxB-
RNA structure in complex with the N-protein (Scha¨rpf et al. 2000).
The RNA is shown in stick presentation and the bound protein is
schematically shown in red. Key nucleotides of the GNRA tetraloop
are colored in green and cyan, and the respective sequence positions
in RMRP are given in parentheses. The G and the A of the tetraloop
form a sheared base pair which will be disrupted by a GrC mutation
in RMRP. The role of the tetraloop structure for RNA-protein inter-
actions is emphasized by the stacking of a tryptophan in the nutboxB-
RNA complex with the N-protein.
were believed to not contain gene-internal elements
(Schramm andHernandez 2002). Alternatively, this mu-
tation may lead to extremely unstable RNA.
Since the rate of growth depends on the synthesis of
proteins, and the synthesis of proteins depends on ri-
bosomes, the regulation of growth must ultimately de-
pend on the regulation of the synthesis of new ribosomes
(Hall et al. 2004). Therefore, we assumed that the no-
vel RMRP mutations observed in anauxetic dysplasia
would have a more pronounced impact on ribosomal
assembly than the known CHH andMDWHmutations.
Mutation of nme1, the RMRP RNA gene homolog in
yeast, impacts late-60S ribosomal assembly via defective
endonuclease cleavage of the precursor subunit 5.8S
rRNA at the ITS-1 A3 site (Schmitt and Clayton 1993;
Henry et al. 1994). The severity of the 5.8S rRNA–
processing defect is directly proportional to the severity
of the growth defect in nme1 mutant yeast (Shadel et
al. 2000). Deﬁciency of a single 60S subunit not only
can lead to the breakdown of the entire particle but also
can disrupt regulatory signals that feed back on ribo-
some biogenesis from the secretory machinery (Zhao et
al. 2003). To investigate the functional impairment re-
sulting from the anauxetic dysplasia mutations, we in-
troduced them in the analogous positions of the yeast
nme1 gene (ﬁg. 5A and 5B). In yeast, the 5.8S rRNA
consists of two main species, 5.8SL and 5.8SS, with a
ratio of 1:10 long to short, generated by two different
pathways (Lindahl et al. 1992; Schmitt and Clayton
1993) (ﬁg. 2). The nme1 gene is required for production
of the 5.8SS species; hence, depletion leads to increased
levels of 5.8SL and reduced 5.8SS (Lindahl et al. 1992;
Schmitt and Clayton 1993; Henry et al. 1994).
In yeast, the anauxetic dysplasia point mutations re-
sulted only in mild growth retardation and reducedmet-
abolic activity, whereas the 5.8SL/5.8SS ratio was un-
altered and the colony size was near normal (ﬁg. 5C).
However, in contrast to gross deletions, single point
mutations in the nme1 gene have resulted only once in
a strong phenotype (Shadel et al. 2000). This may be
explained by the fact that unicellular yeast has an excess
RNase MRP capacity, whereas humans are much more
sensitive to altered activity levels.
Accordingly, expression levels in the cells of a pa-
tient in family 2 (carrying the 90_91AGrGC and
14GrA mutations) showed an increase in uncleaved
pre-5.8S rRNA bound to ITS-1 in ﬁbroblasts and lym-
phocytes, indicating defective rRNA processing. To en-
sure that the effect was RNase MRP dependent, we
transfected the patient’s very poorly growing ﬁbroblasts
with a wild-type RMRP construct, thereby signiﬁcantly
increasing the growth rate and production of the 5.8S
rRNA (ﬁg. 6E and 6F). This is the ﬁrst physiological
demonstration of a function for RNase MRP in mam-
malian cells.
To compare the effects of different RMRP mutations,
we investigated 5.8S rRNA processing in cell constructs
overexpressing the novel anauxetic dysplasia mutations
or the CHH founder mutation (70ArG), respectively
(ﬁg. 7A). Whereas cells transfected with the RMRPwild
type showed a 30-fold increase in cell count in 48 h,
cells transfected with the anauxetic dysplasia mutations
showed only a minor increase in cell count, suggesting
that each of these mutations leads to a nearly complete
disruption of the wild-type function. As the cell count
in the CHH founder mutation showed an intermediate
reduction, the milder clinical phenotype of this mutation
correlates with a minor effect on cell growth in vitro.
As expected, the wild-type transfected cells showed a
shift to higher proportions of cleaved 5.8S rRNA,
whereas all cells transfected with mutant constructs
demonstrated diminished endonucleolytic cleavage at
the ITS-1/5.8S rRNA junction site (ﬁg. 7B). This ef-
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Figure 9 Simpliﬁed overview of the cell cycle–related pathways
impaired in anauxetic dysplasia and CHH. Right, The hereby affected
RMRP gene encodes the untranslated RNA subunit of the ribonucle-
oprotein endoribonuclease, RNase MRP, which is essential for cell
growth and division in yeast and, as our data suggest, also in humans.
One function of the RNase MRP complex is the processing of the
precursor of 5.8S rRNA, which is a subunit of the 60S ribosomal
particle. Therefore, severe and moderate disruption (red ﬂashes) of
RNase MRP function in anauxetic dysplasia and CHH, respectively,
impacts late-60S ribosomal assembly, resulting in a reduced capacity
to synthesize proteins. As a secondary effect, cyclin A2, which pro-
motes G1/S and G2/M phase transitions, is diminished, correlating
with the magnitude of delay in the cell cycle. Left, The second function
of RNase MRP complex in yeast and, apparently, in humans is the
degradation of cyclin B2 mRNA, which is important for the exit of
mitosis. In contrast to anauxetic dyplasia, the latter pathway is also
impacted in CHH, as shown by increased cyclin B2 mRNA levels.
Since cyclin B2 overexpression from different mechanisms contributes
through alterations of the spindle checkpoint to the chromosomal in-
stability observed in some cancers, our ﬁndings could also explain why
only CHH, and not anauxetic dysplasia, is associatedwith proliferative
bone marrow dysfunction and susceptibility to cancer.
fect was most pronounced in the anauxetic dysplasia
mutations.
In addition to its role in rRNA processing, yeast nme1
is involved in cell cycle regulation through degradation
of cyclin B mRNA (Gill et al. 2004). Mutant yeast cells
show increased cyclin B2 mRNA levels and accumulate
in late mitosis (Cai et al. 2002). Cyclin synthesis is es-
sential for entry into mitosis (G2/M transition), and its
degradation marks M-phase exit. Whereas cyclin A2
encoded by CCNA2 promotes both G1/S and G2/M
transitions in the mammalian cell cycle (Pagano et al.
1992), cyclin B2 encoded by CCNB2 is involved in G2/
M transition (Liu et al. 1999). To investigate a similar
function in human RNase MRP, we analyzed CCNA2
and CCNB2 mRNA levels in ﬁbroblasts transfected
with the RMRP mutants (ﬁg. 7C and 7D). Except for
cells with the naturally nonexpressed 14GrA muta-
tion, all cells overexpressing RMRP mutants showed
signiﬁcantly decreased cyclin A2 levels, indicating a pro-
longed cell cycle and correlating with the reduction in
the growth rate and the clinical phenotype. In contrast
to the anauxetic dysplasia mutations, the CHH founder
mutation70ArG had signiﬁcantly increased cyclin B2
mRNA levels, indicating a mitotic delay due to de-
creased mRNA degradation, as seen in yeast mutants.
Since cyclin B2 overexpression from different mecha-
nisms contributes through alterations of the spindle
checkpoint to the chromosomal instability observed in
some cancers (Cai et al. 1999; Sarafan-Vasseur et al.
2002), our ﬁndings could also explain why only CHH,
and not anauxetic dysplasia, is associated with prolif-
erative bone marrow dysfunction and susceptibility to
cancer. Accordingly, mitomycin C sensitivity testing in
ﬁbroblasts of the patient in family 2 revealed no evi-
dence for chromosomal instability in anauxetic dyspla-
sia. Anauxetic dysplasia mutations may, therefore, ge-
netically separate the different functions of RNaseMRP,
processing mRNA normally while poorly processing
rRNA (ﬁg. 9).
We further assume that other phenotypes, including
idiopathic short stature, unclassiﬁed skeletal dysplasias
with spondylo-, meta-, and epiphyseal involvement, and
cancer predisposition, might be caused by distinct mu-
tations in the RMRP gene. With reference to other, so
far etiologically unexplained types of profound short
stature or dwarﬁsm, we believe that the underlying de-
fects are also likely to affect the basic pathways of cell
growth or division.
In conclusion, we show that anauxetic dysplasia is
caused by RMRP mutations and is allelic to CHH and
MDWH. We explain clinical differences by the mag-
nitude and type of alteration in ribosomal assembly and
cyclin-dependent cell cycle regulation. Whereas the
CHH founder mutation affects both pathways inter-
mediately, anauxetic dysplasia mutations do not affect
B-cyclin mRNA levels but severely incapacitate ribo-
somal assembly via defective endonucleolytic cleavage.
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